文献速递运动医学关节外科

Lysholm与KOOS生活质量评分在前交叉韧带重建患者中显示高反应性:随机临床试验的系统综述与Meta分析

Lysholm and KOOS QoL Demonstrate High Responsiveness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
PubMed 文献 · Am J Sports Med · 2024-02-14

该系统综述与Meta分析纳入108篇随机临床试验、9034例前交叉韧带重建患者,比较常用患者报告结局量表的反应性。IKDC是最常用量表,但Lysholm与KOOS生活质量评分的反应性最高。

要点

  • IKDC是前交叉韧带重建随机临床试验中最常报告的患者报告结局量表(68篇,63.0%)。
  • Lysholm与KOOS生活质量评分的相对效率值最高,反应性优于其他量表。
  • ACL生活质量评分效应量最高(3.37),KOOS生活质量评分次之(2.07)。

核心结论

  • 在前交叉韧带重建随机临床试验中,IKDC是最常报告的患者报告结局量表,但Lysholm与KOOS生活质量评分显示出最高的反应性。

研究设计与样本

  • 遵循PRISMA指南,从PubMed/MEDLINE和Web of Science数据库提取英文随机临床试验,最终纳入108篇文章、9034例患者(平均年龄29.9岁,平均体重指数24.3,平均随访时间36.1个月)。
  • 反应性分析纳入标准为报告至少2种患者报告结局量表、至少1年随访、并报告术前和术后量表均值与标准差;采用效应量和相对效率比较量表间的反应性。

主要发现

  • 共识别34种患者报告结局量表,最常报告的3种为IKDC(68篇,63.0%)、Lysholm(65篇,60.2%)和Tegner(47篇,43.5%)。
  • 效应量最高的2种量表为ACL生活质量评分(3.37)和KOOS生活质量评分(2.07)。
  • Lysholm评分的相对效率高于KOOS疼痛(相对效率1.17)、KOOS症状(1.22)、KOOS日常生活活动(1.42)、KOOS运动/娱乐(1.55)、KOOS生活质量(1.41)和Tegner(2.89)评分。
  • KOOS生活质量评分的相对效率高于IKDC(1.32)、KOOS疼痛(1.60)、KOOS症状(2.12)、KOOS日常生活活动(3.03)、KOOS运动/娱乐(1.27)和Tegner(2.06)评分。

关键数值与推荐

  • IKDC报告率63.0%(68/108篇),Lysholm报告率60.2%(65/108篇),Tegner报告率43.5%(47/108篇)。
  • ACL生活质量评分效应量3.37,KOOS生活质量评分效应量2.07。
  • Lysholm评分相对效率高于KOOS疼痛1.17、KOOS症状1.22、KOOS日常生活活动1.42、KOOS运动/娱乐1.55、KOOS生活质量1.41、Tegner 2.89。
  • KOOS生活质量评分相对效率高于IKDC 1.32、KOOS疼痛1.60、KOOS症状2.12、KOOS日常生活活动3.03、KOOS运动/娱乐1.27、Tegner 2.06。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There have been a large number of patient-reported outcome measures (PROMs) used to assess outcomes after anterior cruciate ligament (ACL) reconstruction (ACLR). PURPOSE/HYPOTHESIS: The purpose was to determine which PROMs are being commonly used in randomized clinical trials (RCTs) to assess patients undergoing ACLR and to compare the responsiveness between them. It was hypothesized that the International Knee Documentation Committee (IKDC) score would be the most commonly used and responsive PROM among patients undergoing ACLR. STUDY DESIGN: Meta-analysis. Level of evidence, 2. METHODS: PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines were followed, and relevant studies were extracted from the PubMed/MEDLINE and Web of Science databases. The inclusion criteria were English-language RCTs reporting on PROMs after ACLR. For articles meeting our inclusion criteria for responsiveness analysis (≥2 PROMs reported, 1 year minimum follow-up, and reported pre- and postoperative PROM means and standard deviations), the responsiveness between PROMs was compared using effect size (ES) and relative efficiency (RE). RESULTS: A total of 108 articles met the inclusion criteria, comprising 9034 patients (mean age, 29.9 years; mean body mass index, 24.3; mean follow-up time, 36.1 months). There were 34 PROMs identified. The top 3 most commonly reported PROMs were the IKDC (n = 68; 63.0%), Lysholm (n = 65; 60.2%), and Tegner (n = 47; 43.5%) scores. The 2 PROMs with the highest ES were the ACL-Quality of Life (QoL) (3.37) and Knee Injury and Osteoarthritis Outcome Score (KOOS) QoL (2.07) scores. Compared with other PROMs, Lysholm and KOOS QoL scores had the greatest RE values. The Lysholm score had a greater RE than the KOOS Pain (RE, 1.17), KOOS Symptoms (RE, 1.22), KOOS Activities of Daily Living (ADL) (RE, 1.42), KOOS Sport/Recreation (RE, 1.55), KOOS QoL (RE, 1.41), and Tegner (RE, 2.89) scores. KOOS QoL had a greater RE than the IKDC (RE, 1.32), KOOS Pain (RE, 1.60), KOOS Symptoms (RE, 2.12), KOOS ADL (RE, 3.03), KOOS Sport/Recreation (RE, 1.27), and Tegner (RE, 2.06) scores. CONCLUSION: The IKDC score is the most commonly reported PROM in RCTs after ACLR; however, the Lysholm and KOOS QoL scores demonstrated the highest responsiveness in patients undergoing ACLR compared with other PROMs.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Abed V, Kapp S, Nichols M, et al. Lysholm and KOOS QoL Demonstrate High Responsiveness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Am J Sports Med. 2024. PMID: 38352999. doi:10.1177/03635465231219966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。